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In recent years, it has become widely accepted that functionally distinct T  cell 
subpopulations can be identified by appropriate  surface markers.  For example, 
in  the  mouse,  the  Lyt-2/3  alloantigen  complex  has  been  used  to  define  a 
functional T  cell subset including cells with cytolytic and/or suppressor activity 
(1).  In man,  molecules structurally related to Lyt-2/3 antigens have been iden- 
tified  using  the  monoclonal  antibodies  OKT8  (2),  Leu  2a,  b  (3),  or  B9  (4). 
Initially,  functional  analysis  of T  cell  populations  led  to  the  conclusion  that 
cytolytic  T  lymphocytes  (CTL) l  were  confined  to  the  T8+/T4 -  subset  (5). 
However, this concept was recently challenged by the demonstration that among 
CTL clones some were T8-/T4 + and others T8+/T4 -  (6).  Based on specificity 
analysis of a limited number of alloreactive CTL clones, the suggestion has been 
made that  there  is a  correlation  of T4 and  T8  expression  with  recognition  of 
class II and class I major histocompatibility complex (MHC) products, respectively 
(7). 
It should  be emphasized  that  such studies suffer from several  limitations  in 
interpretation.  First,  there  is the possibility that  CTL clones, because they are 
selected by their ability to be expanded and maintained  in continuous culture, 
are not representative  of the  CTL populations  used for cloning.  More impor- 
tantly,  any  meaningful  interpretation  of these  surface phenotype analyses de- 
pends on the unproven assumption that expression of T4 and T8 antigens is not 
altered during the differentiation and/or proliferation steps that are involved in 
CTL generation and cloning. Indeed, it has been suggested that the Lyt pheno- 
type of functional T  cells can change in the course of activation (8).  Therefore, 
a  more direct approach to the question of surface phenotype of CTL would be 
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to  determine  the  frequency  of CTL  and  CTL-precursors  (CTL-P)  in  T  cell 
subsets derived from activated and normal populations, respectively. With the 
recent  development of limiting dilution microculture techniques allowing the 
development of clonal  progeny from single  CTL-P,  such an  approach  is now 
feasible. For example,  studies in murine systems using negatively or positively 
selected T  cell subsets have shown that >95% of alloreactive CTP-P are confined 
to the Lyt-2  + subset (9). Moreover, using a limiting dilution assay that allows the 
detection of all CTL-P (regardless of their specificity), Wilson et al. (10) reported 
that almost all Lyt-2  + T  cells are CTL-P. 
In this work, we have used a  similar limiting dilution microculture system to 
quantitate precursors of CTL and of other proliferating noncytolytic T  cells in 
human T  cell subsets positively and negatively selected for the expression of B9 
antigen.  As  reported  previously  (11),  virtually  all  peripheral  blood  T  cells 
undergo clonal expansion under the culture conditions used.  It will be shown 
that approximately one-third of all peripheral blood T  cells are CTL-P. -~90% 
of these CTL-P are found in the B9  + subset (which represents 25% of all T  cells). 
Hence, the CTL-P frequency in B9  + cells is virtually 100%, whereas the B9- T 
cell  subset,  which  contains  10%  of all  CTL-P,  has  a  >25-fold  lower  CTL-P 
frequency. Similar results were obtained using B9  + and B9- subsets derived from 
T  cell  populations  activated  in  allogeneic  mixed  leukocyte  (MLC)  cultures. 
Frequency analysis of CTL-P  and CTL  directed against  a  given  set of MHC 
antigens in these two T  cell subsets confirmed these findings. 
Materials and Methods 
Isolation of Lymphoid Cells. 
Purified T  cells were isolated from peripheral blood mononuclear cells (PBMNC)  as 
previously described (2). Adherent cells were removed from PBMNC by incubation on 
plastic petri dishes. Spleen cell suspensions to be used as a source of feeder (or stimulating) 
cells were frozen and subsequently thawed as needed (13). 
Mixed Lymphocyte Cultures. 
Cells were suspended in RPMI 1640 medium containing 10% heat-inactivated fetal calf 
serum (FCS). MLC were set up as previously described (14) by culturing purified T  cells 
either in macrowells (106 cells/well) or in round-bottom microwells  (105 cells/well) with 
equal numbers of irradiated (4,500 rads) allogeneic spleen cells. To evaluate cell prolif- 
eration, tritiated thymidine (3HTdR)  was added to triplicate microwell cultures  18  h 
before harvesting. On day 7,  cells were harvested and centrifuged on Ficoll-Hypaque 
gradients, to remove dead cells. The percentage of E-rosetting cells was then determined. 
When the proportion of E-rosetting cells was >95%, no further purification was per- 
formed. 
Monoclonal Antibody (mAb). 
B9.4 mAb, kindly provided by Dr. Bernard Malissen and Dr. Claude Mawas (Centre 
d'Immunologie INSERM-CNRS,  Marseille-Luminy, France), is derived from BALB/c 
mice immunized with human anti-HLA-A2 cloned cytotoxic T lymphocytes derived from 
immunized donors as previously described in detail (15).  B9.4  mAb binds to surface 
molecules that are similar, if not identical, to those identified by Leu 2a,  Leu 2b, and 
OKT8 mAbs. This conclusion is based on the fact that each one of these mAb reacts with 
the same percentage of peripheral T  cells, and that the percentage of positive T  cells is 
not increased when B9.4 mAb is mixed with either one of the other mAb. Moreover, 
blocking experiments indicate that B9.4 mAb inhibits the binding of Leu 2a, Leu 2b, or MORETTA  ET  AL.  573 
OKT8 mAb to T  cells (A. Moretta, manuscript in preparation). Further information on 
the relationship between antigenic determinants recognized by B9.4 and those recognized 
by the other mAbs has been provided by experiments in which the sensitivity to trypsin 
treatment  has  been  evaluated.  The  antigenic  determinants  recognized  by B9.4  mAb 
exhibit a  trypsin sensitivity similar to those defined by Leu 2b mAb (3)  since they are 
undetectable after treatment of T cells with 30 ~g/ml trypsin for 30 min at 37 °C (Moretta 
et al., manuscript in preparation). In contrast, Leu 2a (3) and OKT8 antigenic determi- 
nants appear to be more resistant to treatment with this dose of trypsin. B9.4 monoclonal 
antibody was used under the form of ascitic fluid diluted in RPMI  1640 (Gibco Labora- 
tories, Grand Island, NY) at a  final dilution of 1/100  (corresponding to  100 ~g/ml of 
antibody). 
Immunofluorescence Staining and Fluorescence-activated Cell Sorter (FACS) Analysis. 
The techniques used have been previously described (16). Briefly, samples of 2 ×  10  ~ 
peripheral blood purified T  cells or MLC T  cells in  100 #! RPMI  1640  medium were 
incubated with 5 t*g of B9.4 monoclonal antibody for 30 min at 4°C. After two washings, 
the cells were resuspended  in  200  #i of medium containing fluorescein isothiocyanate 
(FITC) conjugated goat anti-mouse IgG. Control samples were incubated with the FITC- 
coupled reagent only. After 30 min of incubation at 4°C, all samples were washed three 
times and analyzed on a flow cytometer (FACS II; B-D FACS system, Becton Dickinson 
& Co. Sunnyvale, CA). Results are presented as fluorescence histograms with the number 
of cells on the Y -  axis and the fluorescence intensity on the X -  axis. Both parameters 
are expressed in arbitrary linear units. The percentage of positive cells in each histogram 
is calculated only when the distribution is clearly biphasic. The percentage of cells under 
each peak will be reduced by the percentage of control samples in the same interval of 
fluorescence to yield a net value for percent of positive cells. 
FACS Sorting.  Before  sorting  cells,  the  sample  tubing of  the  FACS  was  flushed 
sequentially with detergent,  sterile distilled water, and 96%  ethanol.  Then,  the tubing 
was rinsed  for 30  rain  with a  solution of gentamycin (50  tzg/ml) in  PBS.  Because the 
fluorescence profiles of cells stained with B9.4 Mab were clearly biphasic (see Fig. 1), <5% 
of all cells had to be discarded because their fluorescence intensity coincided with the 
inflection point of the curve.  Sorted cells were collected in  sterile plastic tubes whose 
inside surfaces had been coated with sterile FCS. Once collected, cells were immediately 
diluted in culture medium. 
Microcultures.  Cells (MLC T  or peripheral blood T  cells) were submitted to vigorous 
mixing (to dissociate possible cell clumps) and then seeded in limiting numbers in round- 
bottom microwells (Greiner,  Nurtingen,  Federal  Republic of Germany) containing  105 
irradiated  (5,000  rads)  feeder cells  in  a  final  volume of 0.2  ml  RPMI  1640  medium 
containing 10% heat-inactivated FCS. Supernatant (SN) from cultures of PHA-stimulated 
human spleen cells (routinely depleted of PHA as described [ 17]) was used as a source of 
T  cell growth factor (TCGF). SN was added (50% vol/vol) either at the onset of the cell 
culture (microcultures containing MLC T  responder cells)  or after 48 h  (microcultures 
containing peripheral blood T  lymphocytes responder cells [ 11 ]). PHA (1% vol/voi) was 
added at the onset of the culture in microplates containing peripheral blood T  cells (11). 
Both types of microcuitures were then supplemented weekly with  105 irradiated feeder 
cells suspended in  100 #1 of TCGF-containing SN.  Controls included irradiated feeder 
cells cultured in the presence of TCGF containing SN or in the presence of both PHA 
and SN (the first type of control was used for microcultures containing MLC T  cells and 
the second one for microcultures containing peripheral blood T  lymphocytes). Plates were 
then incubated at 37"C in a humidified atmosphere of 5% CO2 in air. 
After 14-18 d of culture each microwell was assessed for growth and cytolytic activities. 
Proliferation was determined microscopically as previously described (6). 
Assay of Cytolytic Activity. 
Alloactivated T  cell populations derived from bulk cultures in macrowells were tested 
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tion and from the responding donor cells as described previously (6).  Briefly, varying 
numbers of MLC T  cells were incubated in V-bottom wells of microtiter trays with 5~Cr- 
labeled (5  x  10  s) target cells  (in a  final volume of 200 ~1) thus ensuring lymphocyte/ 
target cell ratios ranging from 6.25:1 to 50:1. Plates were centrifuged at 100 g for 5 min 
and then incubated for 4 h at 37 °C. After incubation the plates were centrifuged at 200 
g for 5 min. Cytolysis was then assessed by counting the radioactivity of 0.1 ml supernatant 
for 1 rain in a gamma counter. Specific lysis was calculated according to the formula: 
Percent specific lysis -- experimental release -  spontaneous release ×  100. 
maximum release -  spontaneous release 
Maximum release was determined by lysing 5~Cr-labeled cells in 0.1  N HCI. Spontaneous 
release from ~Cr-labeled target cells was determined by incubating these cells in culture 
medium. 
Cytolytic activity of individual microcukures in which MLC T  cells were plated under 
limiting conditions was tested against three different types of ~tCr-labeled target cells: (a) 
PHA-induced blasts  derived from the stimulator cell population, (b) autologous PHA- 
induced blasts,  and (c) P815  murine tumor cells in the presence of 1% (vol/vol) PHA 
(11).  To this end, each microculture was split in three 50-#1 aliquots. Each aliquot was 
then tested against a different 5~Cr-labeled target cell population (5 ×  10S/well).  In the 
lectin-dependent cytolytic assay, PHA was added to the ~Cr-labeled P815 cell suspensions 
immediately before distributing the target cells in microwells (to avoid the formation of 
cell clumps). Spontaneous release was determined in control microcultures prepared in 
the same manner as the experimental group, but without the addition of responder cells. 
Cultures in which 5~Cr release exceeded the mean spontaneous release by more than 3 
standard deviations were considered positive for cytolytic activity (11). The same proce- 
dure was used for evaluating the cytolytic activity of microcultures containing peripheral 
blood T  lymphocytes as responder cells. 
Determination  of the Frequency of Proliferating  and/or Cytolytic T 
Lymphocyte Precursors. 
Minimal estimates of the frequencies of proliferating (PTL-P) or cytolytic (CTL-P) T 
lymphocytes were obtained by the minimum chi square method from the Poisson distri- 
bution relationship between the responding cell number and the logarithm of the per- 
centage of nonresponding (negative) cultures (18). 
Results 
Distribution  of B9 Antigen  in Resting  and MLC T  Cells.  The expression of B9 
antigen on human peripheral blood T  cells was studied by indirect immunoflu- 
orescence and cytofluorometric analysis. Freshly isolated (resting) T  cells as well 
as T  cells that had been activated in aliogeneic mixed leukocyte cultures (MLC) 
were  used.  The  fluorescence profiles obtained  with  resting and  MLC  T  cells 
from a  single  donor  are  shown  in  Fig.  1 A  and  B.  A  bimodal  distribution  of 
fluorescence was clearly observed with both populations.  --~25% resting T  cells 
and  ~30%  MLC  T  cells,  were found to express B9 antigen.  In a  series of six 
experiments, the percentage of B9  + cells varied between 20 and 30% in resting 
T  cells and between 20 and 60% in MLC T  cells. T  cell-depleted mononuclear 
cell populations showed no reactivity with  B9  mAb  (data  not shown).  Fig.  1 C 
and D  also shows a  forward light scatter (FLS) analysis of B9  + and B9- MLC T 
cells. In populations of regularly shaped cells, FLS is roughly proportional to the 
square  of the  mean  cellular radius  (19).  It can  be seen  that  both positive and 
negative fractions included small, medium, and large cells. 
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FIGURE  1.  (A) Fluorescence distribution of B9 antigen in human peripheral blood and MLC- 
activated T lymphocytes. T cells were stained with optimum concentrations of B9 monoclonal 
antibody, followed  by appropriate fluoresceinated anti-Ig reagents. Samples were run on FACS 
II gated to exclude nonviable cells. (B) Forward light scatter (FLS) analysis of B9  + and B9- 
MLC human T lymphocytes. 
Expression.  T  cell  populations  stimulated  for  7  d  in  MLC  were  incubated 
sequentially with B9 mAb and fluoresceinated anti-Ig conjugate, and then sorted 
into stained and unstained cells on a  FACS. Given the clear-cut bimodal fluores- 
cence distribution observed under these conditions (Fig.  1), a  precise fractiona- 
tion of MLC T  cells into B9  + and B9- fractions could readily be achieved. The 
cytolytic activities of the two fractions as well as the unfractionated MLC T  cells 
were tested on PHA-induced blast cells bearing the stimulating alloantigens in a 
short-term 5]Cr release assay (20). The results of two representative experiments 
are shown in Fig. 2. 
It  can  be  seen  that  B9-  cell  fractions  had  no  detectable  cytolytic activity. 
Moreover,  dose-response  analysis  showed  that  cytolytic  activity  was  two-  to 
threefold higher  in  B9  ÷ cell fractions as compared with  unfractionated T  cell 
populations. 
Frequency Analysis of Proliferating  and~or CTL Precursors in MLC T Cell Popula- 
tions.  In an attempt to determine the actual frequency of specific CTL in B9  + 
and  B9-  fractions derived  from  MLC  T  cell  populations,  we  used  a  limiting 
dilution  microculture system similar to that previously established in this labo- 
ratory for frequency analysis of alloreactive proliferating and  cytolytic T  lym- 
phocytes in murine lymphoid cell suspensions (21). Graded numbers of cells from 
unfractionated  MLC  populations,  and  from positively and  negatively selected 
B9 + and B9- subpopulations were cultured with allogeneic irradiated spleen cells 
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FIGURE 2.  Cytolytic  activity of MLC-activated  human T cells sorted according to B9 fluo- 
rescence intensity (see Fig. 1). Unfractionated, B9  + and B9- MLC T cells were tested against 
PHA-induced allogeneic blast cells bearing the stimulating alloantigens in a 4-h 5~Cr-release 
assay. The spontaneous release of labeled target cells never exceeded 6% of the total release. 
O, unfractionated; e, B9+; and A, B9- MLC-activated  T cells. 
microcuhure was scored for proliferation by microscopical examination and then 
divided into two aliquots for assay of cytolytic activity. One aliquot was tested 
against 5]Cr-labeled PHA-induced blast cells bearing the stimulating alloantigens, 
whereas  the  other  aliquot  was  tested  against  5~Cr-labeled  autologous  PHA- 
induced blast cells.  The  frequencies of proliferating and/or  cytolytic cells are 
calculated by analysis of the Poisson distribution relationship between the number 
of cells plated per culture and the percentage of negative cultures. The results 
of such an analysis performed on microcultures tested for cytolytic activity against 
the  relevant  allogeneic  target  cells  are  shown  in  Fig.  3.  It  can  be  seen  that 
cytolytic microcuhures were obtained with relatively low numbers of responding 
cells from the B9  + fraction, whereas B9- cells, even at relatively high cell doses, 
generated few cytolytic microcuhures. Since none of the microcuhures exhibited 
cytolytic activity against  autologous  target  cells  (data  not  shown),  it  can  be 
concluded that  the microcuhures cytolytically active on  allogeneic target cells 
contained specific alloreactive CTL derived from a  single or several precursor 
cells. The frequencies of such alloreactive CTL precursors (CTL-P) were calcu- 
lated  by  the  statistical  method  described  by  Taswell  (18).  As  summarized  in 
Table I  (Exp.  1),  the CTL-P frequency was  1 cell in  14 in the unfractionated 
MLC population,  1 cell in  3.3  in the B9  ÷ fraction and  1 cell in 69  in the B9- 
fraction. Similar results were obtained in two additional experiments (Table  I, 
Exp. 2 and 3). Compared with the unfractionated MLC population and the B9- 
fraction, the frequency of specific CTL-P was increased 3.5- and 21-fold, respec- 
tively, in the B9  + fraction. When the proportion of total cells in each fraction 
was  taken  into  account,  it  was  calculated  that  90%  of  the  specific  CTL-P 
recovered after sorting of the MLC population were found in the B9  ÷ fraction 
(Table  I).  In  contrast,  frequency analysis of the precursors  of proliferating T MORETTA  ET  AL.  577 
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FIGURE 3.  Frequency analysis of specific alloreactive CTL-P in MLC T  lymphocytes sepa- 
rated  according to  B9  expression.  Responding  T  cells were stimulated in allogeneic MLC 
against irradiated human spleen cells. After 7 d of culture, the cells were separated by FACS 
sorting into B9 ÷ and  B9- fractions.  Limiting dilution analysis was  performed by culturing 
varying cell doses (ranging from  1 to 20 cells/well) in the presence of irradiated allogeneic 
spleen  cells and  TCGF.  After  18  d  of culture,  each  microcuhure  was  scored  for specific 
cytolytic activity against  S]Crolabeled  PHA-induced blast cells as described in Materials and 
Methods.  Each  point  is  based  on  a  group  of 48  microcultures.  CTL-P  frequencies were 
calculated as described in Materials and Methods. A, unfractionated; e, B9+; and II, B9- T 
cells. 
TABLE  I 
Frequency  Analysis  of  Alloreactive  CTL-P in  MLC  T Cell  Subsets* 
MLC-T popula- 
tion 
Percent of total cells  Reciprocal of CTL-P 
frequency 
Percent of the total 
CTL-P recovered 
Exp. l*  Exp. 2  Exp. 3  Exp. 1  Exp. 2  Exp. 3  Exp. 1  Exp. 2  Exp. 3 
Unfractionated  100  100  100  14.14  12.65  11.5  --  --  -- 
B9 +  30.3  27.1  35  3.34  3.45  4.2  90  91  90.2 
B9-  69.7  72.9  65  69.15  93.45  72.8  10  9  9.8 
* T  lymphocytes activated in primary allogeneic MLC were sorted according to B9  fluorescence 
intensity (see Fig.  1) and assayed for their content of specific alloreactive CTL-P as described in 
Materials and Methods. 
* Data from Fig. 3. 
lymphocytes (PTL-P) in the same populations revealed no significant difference 
between B9 + and B9- fractions. For example, in the experiment corresponding 
to  Fig.  3,  minimal estimates of the PTL-P  frequencies in  the  B9 +,  B9-,  and 
unfractionated populations were determined to be 1 cell in 2.2,  1 cell in 2.3, and 
1 cell in 2.0, respectively (data not shown). Thus these results clearly indicated 
that the majority of MLC B9  ÷ lymphocytes that were capable of proliferation 
were  indeed  specific  alloreactive  CTL-P,  whereas  only  a  minor  fraction  of 
proliferating MLC B9- cells contained such functional precursors. 
From the comparison between PTL-P and CTL-P frequencies in B9  ÷ fractions 578  SUBSET  DISTRIBUTION  OF  HUMAN  CYTOLYTIC  T  LYMPHOCYTES 
(Table I),  it is apparent that a  few of the proliferating microcultures derived 
from such cells were devoid of specific cytolytic activity. This finding could be 
explained by the existence of MLC B9 ÷ cells devoid of lytic potential. Alterna- 
tively, such proliferating, apparently noncytolytic microcultures could be derived 
from CTL-P directed against antigens not expressed by the target cells used. To 
distinguish between these possibilities, experiments were performed in which the 
cytolytic activity of microcuhures obtained under limiting dilution  conditions 
was  determined  in  a  lectin-dependent assay  allowing  the  detection  of CTL 
irrespective of their specificity (11). Fig. 4  shows the results of a representative 
experiment whereby microcultures derived from unfractionated and fractionated 
MLC cells as indicated above were assayed for cytolytic activity against mouse 
P815 tumor target cells in the presence of PHA. Under these conditions, virtually 
all proliferating microcuhures derived from B9  ÷ cells were positive for cytolytic 
activity. Indeed, comparative analysis of the frequency of PTL-P and total CTL- 
P among MLC B9  ÷ cells showed no significant difference (Table II).  It is thus 
evident that most, if not all, MLC B9  + cells are (operationally defined) CTL-P. 
Moreover, it is noteworthy that no increase in CTL-P frequency was observed 
when  microcultures derived  from  MLC  B9-  cells  were  tested  in  the  lectin- 
dependent cytolytic assay (Fig. 4 and Table II), thus confirming the presence of 
low, although significant, numbers of CTL-P in this fraction. 
Frequency Analysis of Proliferating and~or CTL Precursors in Resting T Cell Popu- 
lations.  We have recently reported that virtually all peripheral blood T  lympho- 
cytes can undergo extensive clonal proliferation under optimal culture conditions 
in  vitro  (11).  It  was  therefore of interest  to  use  this  microcuhure system to 
determine the distribution of CTL-P among resting, B9  ÷ and B9- T  cells. To 
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FICVRE 4.  Frequency analysis of total CTL-P in MLC T  lymphocytes separated according 
to B9 expression. The experimental protocol was the same as that described in Fig.  3, with 
the exception that each microculture was assayed for tectin-dependent lysis against 5]Cr-labeled 
P815 murine tumor target cells in the presence of PHA (see Materials and Methods). Each 
point is based on a group of 48 microcultures. CTL-P frequencies were calculated as described 
in Materials and Methods. &, unfractionated; 0, B9+; and II, B9- T  cells. MORETTA  ET  AL. 
TABLE  II 




Percent of total  Reciprocal of PTL- 
cells  P frequency 
Exp.  Exp.  Exp  Exp.  Exp.  Exp. 
1  2  3 *'  1  2  3 
Reciprocal of CTL-P  Percent o/the total 
frequency  CTL-P recovered 
Exp.  Exp.  Exp.  Exp. Exp. Exp. 
1  2  3  1  2  3 
Unfractionated  100  100  I00  2.31  2.36  2.27  9.5  9.1  12  --  --  -- 
B9  ÷  24  25  18  2.25  2.31  2.28  2.25  2.32  2.28  90.1  91.4  87.2 
B9-  76  75  82  2.28  2.36  2.27  64.82  74.10  70.9  9.9  8.6  12.8 
* T  lymphocytes activated  in primary allogeneic MLC were sorted according  to B9 fluorescence 
intensity (see Fig. 1) and assayed for their content  of total  PTL-P and CTL-P as described  in 
Materials and Methods. 
* Data from Fig. 4. 
TABLE  III 
Frequency Analysis of Total PTL-P and CTL-P in Peripheral Blood T Cell Subsets* 
Experiment  Cell source 
number 
Frequency (95% confidence limits) 
Proliferation  P815 + PHA (LDCC) 
2* 
Unfractionated  peripheral  blood  0.94 (0.82-1.06) 
T cells  0.95 (0.79-1.11) 
B9  ÷ T cells  1.05 (0.93-1.17) 
B9- T cells 
Unfractionated  T cells  1.02 (0.92-1.12) 
B9  ÷ T cells  1.00 (0.86-1.14) 
B9- T cells  1.03 (0.94-1.12) 
O.32  (0.25-O.38) 
0.96  (0.79-1.13) 
0.012 (0.009-0.015) 
0.34  (0.23-0.45) 
1.01  (0.82-1.20) 
0.026 (0.014-0.037) 
* Peripheral  blood T  lymphocytes from two different donors were sorted according to B9 fluores- 
cence intensity (see Fig. 1) and cultured under optimal conditions, which allows the clonal expansion 
of all human T cells (see Materials and Methods). After 18 d of culture  total PTL-P and CTL-P 
were determined (see Materials and Methods). 
* Data from Fig. 5. 
this end, peripheral blood T  cells were stained with B9 mAb and sorted into B9 ÷ 
and Bg- fractions on the  FACS.  Graded numbers of cells from each fraction as 
well as unfractionated  T  cells were plated  in  the  presence of irradiated  spleen 
(feeder) cells and PHA. After 48 h, TCGF-containing supernatant was added to 
each microcuiture.  After incubation  for  18  d,  microcultures  were assessed  for 
proliferation and cytolytic activity. In agreement with our previous report (11), 
the frequency of proliferating cells in unfractionated T  cells was essentially 100% 
(Table III). Moreover, this high cloning efficiency was unaffected by the staining 
and/or  sorting procedure since both B9 ÷ and  B9- fractions exhibited a  similar 
clonogenic potential (Table III). 
The cytolytic activity of the limiting dilution  microcultures was assayed using 
lectin-dependent  assay system.  Fig.  5  shows semi-log plots of the data obtained 
in  a  representative  experiment.  In  all  groups  of responder  cells,  there  was  a 
linear relationship between the number of responder cells cultured  and the log 
of the  proportion  of noncytolytic  cultures.  The  results  of CTL-P  frequency 
estimates are  summarized  in  Table  III.  In  unfractionated  resting  T  cells,  the 
frequency  of CTL-P  was  ~0.33  or  1  cell  in  3.  The  CTL-P  frequency  was 580  SUBSET  DISTRIBUTION  OF  HUMAN  CYTOLYTIC  T  LYMPHOCYTES 
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FIGURE 5.  Frequency analysis of total CTL-P in peripheral blood T  lymphocytes separated 
according to B9 expression. Peripheral blood T  lymphocytes were separated by FACS sorting 
into B9 ÷ and B9- fractions. Limiting dilution analysis was performed by culturing different 
cell doses (ranging from 0.5  to 8  cells/well) in the presence of irradiated allogeneic spleen 
cells and PHA. TCGF was added 48 h later. At the end of the culture period each microculture 
s~  was assayed  for lectin-dependent cytolytic activity against  Cr-labeled P815  murine tumor 
target cells in the presence of PHA. Each point is based on a group of 48 microcultures CTL- 
P frequencies were determined as described in Materials and Methods. A, unfractionated; @, 
B9÷; and II, B9- T  cells. 
increased threefold in the  B9  + fraction,  thus indicating  that essentially all B9  ÷ 
cells in peripheral  blood are CTL-P.  In contrast,  the CTL-P frequency in  the 
B9- fraction (which represented  70-80%  of the total T  cells) was very low (1/ 
38;  1/83). 
In view of these results, it was of interest to determine the frequency of CTL- 
P  directed  against  a  given  alloantigen  set  in  unfractionated  and  fractionated 
peripheral blood T  cells. To this end, microcultures were established with graded 
numbers of responder cells from the various populations tested above, irradiated 
allogeneic spleen cells (without PHA) and an appropriate source of TCGF. After 
18 d, the cytolytic activity of each microculture was tested against PHA-induced 
blast  cells  bearing  the  stimulating  alloantigens.  Minimal  estimates  of specific 
alloreactive  CTL-P  obtained  under  these  conditions  are  shown  in  Fig.  6  and 
Table  IV.  In  a  series  of three  experiments,  mean  CTL-P  frequencies  were 
determined  to be  1/2,340,  1/573,  and  1/14,266  in  unfractionated,  B9  + and 
B9- cells, respectively. Thus, there was a 25-fold difference in CTL-P frequency 
between B9  + and B9- resting T  cells. 
Discussion 
In this work, we have combined a high efficiency microculture cloning system 
with positive selection on a FACS to assess directly the B9 phenotype of human 
CTL and their precursors in normal and MLC T  cell populations. From limited 
structural  analysis,  it  appears  that  the  molecules  bearing  the  B9  antigen  are 
related to those defined by monoclonal antibodies of the OKT8 and Leu-2 series MORETTA  ET  AL.  581 
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FIGURE 6.  Frequency analysis of specific alloreactive CTL-P in peripheral blood T  lympho- 
cytes separated according to B9 expression. The experimental protocol was the same as that 
described in Fig. 5, with the exception that the responder cells were cultured in the presence 
of irradiated allogeneic spleen cells and TCGF (without PHA). After 18 d  of culture, each 
group  of microculture was  tested  for  specific  cytolytic activity against SlCr-labeled PHA- 
induced blast cells bearing the stimulating alloantigens. Each point is based on a group of 48 
microcultures. CTL-P frequencies were calculated as described in Materials and Methods. A, 
unfractionated; O, B9+; and.,  B9- T  cells. 
TABLE  IV 
Frequency Analysis of Alloreactive CTL-P in Peripheral Blood T Cell 
Subsets* 
Reciprocal of CTL-P frequency 
Cell population 
Exp. 1'  Exp. 2  Exp. 3 
Unfractionated T cells  2,800  2,200  2,010 
B9  + T  cells  710  550  460 
B9- T  cells  16,400  14,800  11,600 
* Peripheral blood T lymphocytes from three different donors were sorted 
according to B9 fluorescence intensity (see Fig. 1) and assayed for their 
content ofalloreactive CTL-P as described in the Materials and Methods. 
* Data from Fig. 6. 
(4, 22). Preliminary results concerning the sensitivity of the antigenic determinant 
defined by the B9.4 monoclonal antibody to mild trypsin treatment suggest that 
this determinant is closely related, if not identical, to that defined by the Leu 2b 
monoclonal antibody (A. Moretta, unpublished observation). In peripheral blood 
T  cells, 25% cells were B9 positive as assessed by indirect immunofluorescence 
and flow microfluorometry. The percentage of B9  + cells was more variable in T 
cell populations that had been stimulated in allogeneic MLC, ranging from 20 
to 60%. 
In the first part of this study, our aim has been to determine the frequency 
and B9 phenotype of the CTL that are present in MLC populations. Although 
a  direct approach  to  this  question would be  to examine individual CTL,  the 582  SUBSET  DISTRIBUTION OF  HUMAN  CYTOLYTIC T  LYMPHOCYTES 
methods  available  for  detecting  CTL  at  the  single  cell  level  are  not  easily 
amenable to the study of their surface phenotype. Therefore, we turned to the 
more practical approach of determining the surface phenotype of the MLC cells 
that produce a  CTL progeny upon appropriate stimulation in limiting dilution 
microcultures. Although this has not been formally proven in a human system, 
previous studies in the mouse using similar microculture systems indicate that 
CTL can give rise to a cytolytic progeny upon stimulation in microcultures (23). 
We therefore assume that the (operationally defined) CTL-P in MLC populations 
correspond to  the CTL  themselves.  It  should be emphasized that,  under the 
culture conditions used, the frequency of MLC T  cells that underwent extensive 
proliferation  was  as  high  as  40-60%.  Given  this  high  cloning efficiency, we 
conclude that the CTL-P frequencies obtained by limiting dilution analysis of 
MLC T  cells are representative of the actual CTL frequencies in these popula- 
tions. 
Two different target cell systems were used to analyze the cytolytic activity of 
the limiting dilution microcultures, established with MLC T  cells, namely PHA- 
induced blast cells derived from the lymphoid population used as the source of 
(allogeneic) stimulators in MLC, and murine (P815) tumor cells in conjunction 
with PHA. With the latter system, CTL activity can be detected regardless of 
the antigenic specificity of the effector cells (11, 24). Thus, by using these two 
assays systems, we have been able to compare directly the frequencies of CTL-P 
specifically directed against the MHC alloantigens of the stimulators with those 
of all CTL-P present in MLC populations.  For simplicity, these frequencies are 
further referred to as frequencies of specific and total CTL-P, respectively. 
The results of several independent experiments indicated that the frequency 
of total CTL-P in  MLC T  cell populations was  ~1  in  10.  The large majority 
(___90%) of these CTL-P were found in the B9  + subset. Moreover, the frequency 
of total  CTL-P in  MLC  B9  ÷ cells was always identical to that of proliferating 
cells, whereas <1  in 20 proliferating B9- cells produced a cytolytic progeny. As 
evidenced by the frequency analysis of specific CTL-P, the great majority of the 
CTL-P detected in the lectin-dependent assay were directed against the stimu- 
lating  alloantigens.  Taken  together,  these results  thus  suggest that  most  B9 ÷ 
MLC cells, all of which appear to have a  cytolytic potential, are specific CTL, 
whereas the frequency of such effector cells is much lower in B9- MLC cells. 
In order to relate these findings to the characterization of CTL-P in unprimed 
T  cell populations, we took advantage of the availability of a recently developed 
microculture system that allows clonal expansion of virtually every peripheral 
blood T  lymphocyte (11). Using this system, we demonstrated previously that 1 
peripheral blood T  cell in 3 is a CTL-P. The work presented here confirms and 
extends these findings to the distribution of the peripheral blood CTL-P in the 
two  subsets  defined  by  the  B9.4  monoclonal  antibodies.  As  in  the  studies 
concerning the surface phenotype of MLC CTL-P, the relationship between B9 
phenotype and CTL-P frequencies was examined by positive selection using the 
FACS to separate B9  + and B9- cells in peripheral blood T  cell populations.  It 
should be emphasized that the high cloning efficiency observed with unseparated 
T  lymphocytes was unaffected by the staining and/or sorting procedure. Since 
the frequency of proliferating cells was essentially 100% with both B9 + and B9- MORETTA  ET  AL.  583 
cells, a  quantitative assessment of the CTL-P distribution in these two subsets 
could readily be obtained. The results demonstrate that >90%  of total CTL-P 
in peripheral blood express the B9  ÷ phenotype. It is of interest that this value is 
comparable to that of total CTL-P in mouse spleen that are Lyt-2  + (10). 
Our finding that the frequency of total CTL-P in the B9  + subset is essentially 
100% was somewhat unexpected in view of the reports indicating that this subset 
also contains T  suppressor cells.  Although it cannot be excluded that a  small 
fraction of T  cells is unable to grow under our culture conditions, the demon- 
stration  that  most,  if not  all,  B9  +  cells  in  peripheral  blood  have  a  cytolytic 
potential suggests that this subset contains very few cells with suppressor activity, 
or, alternatively, CTL-P may exhibit suppressor activity. 
While the vast majority of CTL-P were included in the B9  ÷ subset, a  small, 
although significant,  number of them was detectable in  the B9-  subset.  This 
finding cannot be explained by a  contamination of B9- cells by B9  ÷ cells since 
cytofluorometric analysis of the few cytolytic microcultures derived from B9- 
cells clearly indicated that these cultures contained only B9- cells (A. Moretta, 
unpublished observation).  If one assumes that the B9- subset is similar to the 
OKT4 + subset, our results are then consistent with the recent demonstration of 
CTL clones expressing the T4+/T8 -  phenotype (6, 7). As shown here, CTL-P 
expressing  this  phenotype are  relatively rare  (<10%  of total  CTL-P  pool  in 
peripheral blood). 
In line with recent reports concerning the frequency of alloreactive CTL-P in 
murine  lymphoid populations  (25),  comparison  of the  frequencies of CTL-P 
directed against a set of MHC alloantigens in unprimed T  cells and day 7 MLC 
T  cells revealed that  these frequencies increased >200-fold following in vitro 
stimulation in bulk cultures (Tables I and IV). It is of interest that the magnitude 
of this  increase was  similar among  B9  + and  B9-  CTL-P  despite  the  25-fold 
difference in CTL-P frequency between the two subsets. 
In conclusion, this work provides for the first time a quantitative assessment 
of the size and subset distribution of the total CTL-P pool in unprimed and in 
vitro  primed  peripheral  blood  human  T  cells.  In  view  of the  high  cloning 
efficiency of the microculture system used, it is now possible to perform similar 
studies  concerning noncytolytic functional  T  cells.  Studies  along  these  lines 
should  provide  a  more  accurate  understanding  of the  relationship  between 
expression of surface markers and functional activities of human T  cells. 
Summary 
In order to directly assess the distribution of cytolytic T  lymphocytes (CTL) 
and their precursors (CTL-P) in the two major subsets of human T cells, we have 
used limiting dilution microculture systems to determine their frequencies. The 
two subsets were defined according to their reactivity (or lack thereof) with B9.4 
monoclonai antibody (the specificity of which is similar, if not identical, to that 
of Leu  2b monoclonal antibody). Both  B9  + and B9- cells obtained by sorting 
peripheral  blood  resting  T  cells  using  the  fluorescence-activated cell  sorter 
(FACS) were assayed for total CTL-P frequencies in a microculture system that 
allows clonal growth of every T  ceil. As assessed by a  lectin-dependent assay, 
,~30%  of peripheral  blood  T  cells  were  CTP-P.  In  the  B9  +  subset  (which 584  SUBSET  DISTRIBUTION  OF  HUMAN CYTOLYTIC T  LYMPHOCYTES 
represents  20-30%  of all  T  cells),  the  CTL-P  frequency was  close  to  100%, 
whereas the B9- subset had a  25-fold lower CTL-P frequency. It is thus evident 
that 90%  and  10%  of the total CTL-P in peripheral blood are confined to the 
B9 + or  B9-  T  cell  subsets,  respectively. Analysis of the  subset distribution of 
CTL-P directed against a given set of alloantigens confirmed these findings. 
CTL-P frequencies were also determined in B9  + and B9- subsets derived from 
T  cells  that had  been  activated in  allogenic  mixed leucocyte cultures  (MLC). 
~10%  of MLC T  cells were CTL-P. This frequency was increased 3.5-fold in 
the B9  + subset, whereas the B9- subset contained only a small, although detect- 
able  number  of CTL-P.  Moreover,  the  great  majority  of the  (operationally 
defined) CTL-P in MLC T  cell population were found to be directed against the 
stimulating ailoantigens, thus indicating a  dramatic increase in specific CTL-P 
frequencies following in vitro stimulation in bulk cultures. 
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